BCRX EBITDA Margin
Biocryst Pharmaceuticals Inc · EBITDA Margin
BCRX EBITDA Margin
Latest reported-32.21%period ending
BCRX EBITDA Margin (-885.71% → -32.21%)
Annual ebitda margin
High-resolution chart · PNG
BCRX ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 39.7391% | |
| 2.8417% | |
| -35.1028% | |
| -53.1166% | |
| -77.4563% | |
| -940.7422% | |
| -197.1557% | |
| -437.5393% | |
| -224.3826% | |
| -182.8027% | |
| -77.997% | |
| -294.0476% | |
| -144.4002% | |
| -128.5019% | |
| -266.1915% | |
| -49.7407% | |
| -15.8723% | |
| -40.8507% | |
| -38.8639% | |
| -688.9424% | |
| -16,615.987% | |
| -5,976.4358% | |
| -769.8176% | |
| -983.7329% | |
| -35.277% | |
| -276.3547% | |
| -304% | |
| -85.9375% | |
| -1,170% | |
| -303.7037% | |
| -4,250% | |
| -885.7143% |